
NeuroDR's FDA clearance: what it means for physicians
NeuroDR cleared FDA 510(k) for head-and-neck CTA visualisation. What that clearance means for physicians who want imaging AI advisory roles.
The physicians turning expertise into advisory work, board seats and new sources of income. Their stories, and your next steps.

NeuroDR cleared FDA 510(k) for head-and-neck CTA visualisation. What that clearance means for physicians who want imaging AI advisory roles.

Industry and healthtech advisory seats rarely show up on job boards. Here is how physicians actually get invited, what the work pays in practice, and a seven-day plan you can run without quitting clinic.

You can earn paid industry and healthtech consulting without quitting practice. Here is the map of engagement types, honest rate bands, a first-invoice path, and the contract checks to run first.

Sponsors use “KOL” to mean peer trust in a therapeutic niche, not TikTok reach. Here is a quiet proof ladder physicians can run without becoming influencers.

NeuroDR cleared FDA 510(k) for head-and-neck CTA visualisation. What that clearance means for physicians who want imaging AI advisory roles.

Arcutis appointed Rob Scott, MD to its board. A clear case study in what commercial-stage companies look for when they hire a physician director.

Vera Health raised $28.5M for clinical AI search. What this funding round means for physicians who want advisory, board and consulting visibility.

Industry and healthtech advisory seats rarely show up on job boards. Here is how physicians actually get invited, what the work pays in practice, and a seven-day plan you can run without quitting clinic.

You can earn paid industry and healthtech consulting without quitting practice. Here is the map of engagement types, honest rate bands, a first-invoice path, and the contract checks to run first.

Sponsors use “KOL” to mean peer trust in a therapeutic niche, not TikTok reach. Here is a quiet proof ladder physicians can run without becoming influencers.

Compare personal branding agencies and personal brand management companies for doctors by outcome: referrals vs industry invitations, with criteria and a table.

The difference between being asked for a favour and being retained as an advisor is rarely clinical ability. It is legibility.

Governance appointments almost never come from applications. They come from a named person who can already defend the choice.

Clinicians do not lack relevant experience. They lack a translation of it that a founder or hiring committee can act on.

Not every doctor wants an audience. Commercial demand does not require one.

Physicians routinely underprice advisory work because they anchor to an hourly clinical wage rather than to the value of the decision.

Professional standards are not the reason doctors stay invisible. Uncertainty about them is.